Global Monoclonal Antibody Development Services Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06251043

Publication Date:

June 27, 2025

Pages:

140

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Monoclonal Antibody Development Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Monoclonal antibody development services are antibody preparation services tailored to the specific needs of clients. The goal is to generate highly specific and affinity matured monoclonal antibodies for the detection and analysis of specific target molecules. These services are typically provided by specialized antibody development companies, where clients can provide their target antigen or receive guidance to select the most appropriate antigen. The service usually includes immunization of animals with the antigen, hybridoma fusion and screening for monoclonal antibodies, and validation and purification of the monoclonal antibodies. These monoclonal antibodies can be used for various applications, such as immunohistochemistry, immunoblotting, immunoprecipitation, flow cytometry, ELISA, and more.
United States market for Monoclonal Antibody Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Monoclonal Antibody Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Monoclonal Antibody Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Monoclonal Antibody Development Services players cover Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢onoclonal Antibody Development Services Industry Forecast鈥� looks at past sales and reviews total world Monoclonal Antibody Development Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Development Services sales for 2025 through 2031. With Monoclonal Antibody Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Development Services industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monoclonal Antibody Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Monoclonal Antibody Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Development Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Development Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Development Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Small-scale
Medium-sclae
Large-scale
Segmentation by Application:
Biopharmaceuticals
Medical Diagnosis
Agricultural
Medical Treatment
Environmental monitoring
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurogentec
ProSci
Syd Labs
Promab
Antibodies Inc
Bhat Biotech
Synaptic Systems
Covalab
CePower
Lampire Biological Laboratories
Leinco Technologies
Medimabs
Davids Bioengineering
Scantibodies
Abwiz Bio
Thermo Fisher Scientific

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Development Services Market Size (2020-2031)
2.1.2 Monoclonal Antibody Development Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Monoclonal Antibody Development Services by Country/Region (2020, 2024 & 2031)
2.2 Monoclonal Antibody Development Services Segment by Type
2.2.1 Small-scale
2.2.2 Medium-sclae
2.2.3 Large-scale
2.3 Monoclonal Antibody Development Services Market Size by Type
2.3.1 Monoclonal Antibody Development Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Monoclonal Antibody Development Services Market Size Market Share by Type (2020-2025)
2.4 Monoclonal Antibody Development Services Segment by Application
2.4.1 Biopharmaceuticals
2.4.2 Medical Diagnosis
2.4.3 Agricultural
2.4.4 Medical Treatment
2.4.5 Environmental monitoring
2.4.6 Others
2.5 Monoclonal Antibody Development Services Market Size by Application
2.5.1 Monoclonal Antibody Development Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Monoclonal Antibody Development Services Market Size Market Share by Application (2020-2025)
3 Monoclonal Antibody Development Services Market Size by Player
3.1 Monoclonal Antibody Development Services Market Size Market Share by Player
3.1.1 Global Monoclonal Antibody Development Services Revenue by Player (2020-2025)
3.1.2 Global Monoclonal Antibody Development Services Revenue Market Share by Player (2020-2025)
3.2 Global Monoclonal Antibody Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Monoclonal Antibody Development Services by Region
4.1 Monoclonal Antibody Development Services Market Size by Region (2020-2025)
4.2 Global Monoclonal Antibody Development Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Monoclonal Antibody Development Services Market Size Growth (2020-2025)
4.4 APAC Monoclonal Antibody Development Services Market Size Growth (2020-2025)
4.5 Europe Monoclonal Antibody Development Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Monoclonal Antibody Development Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Monoclonal Antibody Development Services Market Size by Country (2020-2025)
5.2 Americas Monoclonal Antibody Development Services Market Size by Type (2020-2025)
5.3 Americas Monoclonal Antibody Development Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody Development Services Market Size by Region (2020-2025)
6.2 APAC Monoclonal Antibody Development Services Market Size by Type (2020-2025)
6.3 APAC Monoclonal Antibody Development Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Monoclonal Antibody Development Services Market Size by Country (2020-2025)
7.2 Europe Monoclonal Antibody Development Services Market Size by Type (2020-2025)
7.3 Europe Monoclonal Antibody Development Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Monoclonal Antibody Development Services by Region (2020-2025)
8.2 Middle East & Africa Monoclonal Antibody Development Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Monoclonal Antibody Development Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Monoclonal Antibody Development Services Market Forecast
10.1 Global Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.1.1 Global Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.1.2 Americas Monoclonal Antibody Development Services Forecast
10.1.3 APAC Monoclonal Antibody Development Services Forecast
10.1.4 Europe Monoclonal Antibody Development Services Forecast
10.1.5 Middle East & Africa Monoclonal Antibody Development Services Forecast
10.2 Americas Monoclonal Antibody Development Services Forecast by Country (2026-2031)
10.2.1 United States Market Monoclonal Antibody Development Services Forecast
10.2.2 Canada Market Monoclonal Antibody Development Services Forecast
10.2.3 Mexico Market Monoclonal Antibody Development Services Forecast
10.2.4 Brazil Market Monoclonal Antibody Development Services Forecast
10.3 APAC Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.3.1 China Monoclonal Antibody Development Services Market Forecast
10.3.2 Japan Market Monoclonal Antibody Development Services Forecast
10.3.3 Korea Market Monoclonal Antibody Development Services Forecast
10.3.4 Southeast Asia Market Monoclonal Antibody Development Services Forecast
10.3.5 India Market Monoclonal Antibody Development Services Forecast
10.3.6 Australia Market Monoclonal Antibody Development Services Forecast
10.4 Europe Monoclonal Antibody Development Services Forecast by Country (2026-2031)
10.4.1 Germany Market Monoclonal Antibody Development Services Forecast
10.4.2 France Market Monoclonal Antibody Development Services Forecast
10.4.3 UK Market Monoclonal Antibody Development Services Forecast
10.4.4 Italy Market Monoclonal Antibody Development Services Forecast
10.4.5 Russia Market Monoclonal Antibody Development Services Forecast
10.5 Middle East & Africa Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Monoclonal Antibody Development Services Forecast
10.5.2 South Africa Market Monoclonal Antibody Development Services Forecast
10.5.3 Israel Market Monoclonal Antibody Development Services Forecast
10.5.4 Turkey Market Monoclonal Antibody Development Services Forecast
10.6 Global Monoclonal Antibody Development Services Forecast by Type (2026-2031)
10.7 Global Monoclonal Antibody Development Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Monoclonal Antibody Development Services Forecast
11 Key Players Analysis
11.1 Eurogentec
11.1.1 Eurogentec Company Information
11.1.2 Eurogentec Monoclonal Antibody Development Services Product Offered
11.1.3 Eurogentec Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Eurogentec Main Business Overview
11.1.5 Eurogentec Latest Developments
11.2 ProSci
11.2.1 ProSci Company Information
11.2.2 ProSci Monoclonal Antibody Development Services Product Offered
11.2.3 ProSci Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 ProSci Main Business Overview
11.2.5 ProSci Latest Developments
11.3 Syd Labs
11.3.1 Syd Labs Company Information
11.3.2 Syd Labs Monoclonal Antibody Development Services Product Offered
11.3.3 Syd Labs Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Syd Labs Main Business Overview
11.3.5 Syd Labs Latest Developments
11.4 Promab
11.4.1 Promab Company Information
11.4.2 Promab Monoclonal Antibody Development Services Product Offered
11.4.3 Promab Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Promab Main Business Overview
11.4.5 Promab Latest Developments
11.5 Antibodies Inc
11.5.1 Antibodies Inc Company Information
11.5.2 Antibodies Inc Monoclonal Antibody Development Services Product Offered
11.5.3 Antibodies Inc Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Antibodies Inc Main Business Overview
11.5.5 Antibodies Inc Latest Developments
11.6 Bhat Biotech
11.6.1 Bhat Biotech Company Information
11.6.2 Bhat Biotech Monoclonal Antibody Development Services Product Offered
11.6.3 Bhat Biotech Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bhat Biotech Main Business Overview
11.6.5 Bhat Biotech Latest Developments
11.7 Synaptic Systems
11.7.1 Synaptic Systems Company Information
11.7.2 Synaptic Systems Monoclonal Antibody Development Services Product Offered
11.7.3 Synaptic Systems Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Synaptic Systems Main Business Overview
11.7.5 Synaptic Systems Latest Developments
11.8 Covalab
11.8.1 Covalab Company Information
11.8.2 Covalab Monoclonal Antibody Development Services Product Offered
11.8.3 Covalab Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Covalab Main Business Overview
11.8.5 Covalab Latest Developments
11.9 CePower
11.9.1 CePower Company Information
11.9.2 CePower Monoclonal Antibody Development Services Product Offered
11.9.3 CePower Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 CePower Main Business Overview
11.9.5 CePower Latest Developments
11.10 Lampire Biological Laboratories
11.10.1 Lampire Biological Laboratories Company Information
11.10.2 Lampire Biological Laboratories Monoclonal Antibody Development Services Product Offered
11.10.3 Lampire Biological Laboratories Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lampire Biological Laboratories Main Business Overview
11.10.5 Lampire Biological Laboratories Latest Developments
11.11 Leinco Technologies
11.11.1 Leinco Technologies Company Information
11.11.2 Leinco Technologies Monoclonal Antibody Development Services Product Offered
11.11.3 Leinco Technologies Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Leinco Technologies Main Business Overview
11.11.5 Leinco Technologies Latest Developments
11.12 Medimabs
11.12.1 Medimabs Company Information
11.12.2 Medimabs Monoclonal Antibody Development Services Product Offered
11.12.3 Medimabs Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Medimabs Main Business Overview
11.12.5 Medimabs Latest Developments
11.13 Davids Bioengineering
11.13.1 Davids Bioengineering Company Information
11.13.2 Davids Bioengineering Monoclonal Antibody Development Services Product Offered
11.13.3 Davids Bioengineering Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Davids Bioengineering Main Business Overview
11.13.5 Davids Bioengineering Latest Developments
11.14 Scantibodies
11.14.1 Scantibodies Company Information
11.14.2 Scantibodies Monoclonal Antibody Development Services Product Offered
11.14.3 Scantibodies Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Scantibodies Main Business Overview
11.14.5 Scantibodies Latest Developments
11.15 Abwiz Bio
11.15.1 Abwiz Bio Company Information
11.15.2 Abwiz Bio Monoclonal Antibody Development Services Product Offered
11.15.3 Abwiz Bio Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Abwiz Bio Main Business Overview
11.15.5 Abwiz Bio Latest Developments
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Information
11.16.2 Thermo Fisher Scientific Monoclonal Antibody Development Services Product Offered
11.16.3 Thermo Fisher Scientific Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Thermo Fisher Scientific Main Business Overview
11.16.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂